Key Statistics for 4523
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (JPY) (ttm)
|Est. EPS (JPY) (03/2014)
|Est. PEG Ratio
|Market Cap (M JPY)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (JPY)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 4523
- Net Income (M/JPY)
Eisai Co., Ltd. produces prescription drugs and medical equipment and sells mainly to sales agents and subsidiaries. Through its subsidiary, Sanko Junyaku, the Company produces and sells diagnostic drugs. Eisai also markets its products through related companies in the US, Europe, and Asia. The Company also manufactures and sells foods, livestock feeds, chemical, and agrochemicals.
More Company Profile & Key Executives for 4523
|Haruo NaitoPresident/CEO||Lynn KramerPresdent:Neuroscience|
|Hideshi HondaDeputy President||Hajime ShimizuDeputy President|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries